Fonte: The Pharmacogenomics Journal. Unidades: FMRP, FM
Assuntos: FARMACOGENÉTICA, NANISMO, VARIAÇÃO GENÉTICA, HORMÔNIO DO CRESCIMENTO (DEFICIÊNCIA;TERAPIA;USO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTALONGA, Everlayny Fiorot et al. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.13. Acesso em: 24 set. 2024.APA
Costalonga, E. F., Antonini, S. R. R., Guerra Júnior, G., Coletta, R. R. D., Franca, M. M., Braz, A. F., et al. (2011). Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal. doi:10.1038/tpj.2011.13NLM
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2024 set. 24 ] Available from: https://doi.org/10.1038/tpj.2011.13Vancouver
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2024 set. 24 ] Available from: https://doi.org/10.1038/tpj.2011.13
